1. Use of Animal Models in Understanding Cancer-induced Bone Pain
   Lauren M. Slosky et al, 2015, Cancer Growth and Metastasis CrossRef
2. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
   Marco Infante et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
3. Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
   Dirk Geerts et al, 2020, Frontiers in Oncology CrossRef
4. Bone Health in Prostate Cancer
   Eugene Pietzak et al, 2016, Prostate Cancer CrossRef
5. Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat model
   Yue Sun et al, 2017, Oncology Letters CrossRef
6. Animal Models of Cancer-Related Pain: Current Perspectives in Translation
   Jorge B. Pineda-Farias et al, 2020, Frontiers in Pharmacology CrossRef
7. OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone
   Penelope D. Ottewell et al, 2015, International Journal of Cancer CrossRef
8. Osteoprotegerin in breast cancer: beyond bone remodeling
   Michael Weichhaus et al, 2015, Molecular Cancer CrossRef
9. A framework for the development of effective anti-metastatic agents
   Robin L. Anderson et al, 2019, Nature Reviews Clinical Oncology CrossRef
10. BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells
    Shaoheng Wan et al, 2014, Cellular Oncology CrossRef
11. Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells
    Stephanie Tsang Mui Chung et al, 2017, Molecular Cancer CrossRef
12. Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives
    Sioned Owen et al, 2017, Translational Research in Breast Cancer CrossRef
13. Peroxidase enzymes inhibit osteoclast differentiation and bone resorption
    Vasilios Panagopoulos et al, 2017, Molecular and Cellular Endocrinology CrossRef
14. PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
    Jacqueline E. Noll et al, 2015, Journal of Hematology & Oncology CrossRef
15. Dynamic interplay between bone and multiple myeloma: Emerging roles of the osteoblast
    Michaela R. Reagan et al, 2015, Bone CrossRef
16. Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction
    Mingshuai Ying et al, 2023, Journal of Personalized Medicine CrossRef
17. Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro
    SIONED OWEN et al, 2016, International Journal of Oncology CrossRef
18. Adriamycin in combination with dexamethasone and octreotide lacks activity on the treatment of a 4T1 metastatic breast cancer model
    Panayiotis Dalezis et al, 2017, Anti-Cancer Drugs CrossRef
19. Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond
    Maria V. Deligiorgi et al, 2020, Clinical & Experimental Metastasis CrossRef
20. Integration of whole‐genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple‐negative breast cancer
    Guangdong Xie et al, 2019, International Journal of Cancer CrossRef